Gilead’s Trodelvy May Have Safety Edge Due To Lack Of Concerning Lung Toxicity

Executives said there had been no cases of interstitial lung disease, while ILD – including fatal events – has become a potential problem for AstraZeneca/Daiichi Sankyo’s dato-DXd.